“Deficiency” of Mitochondria in Muscle Does Not Cause Insulin Resistance
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Based on evidence that patients with type 2 diabetes (T2DM), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with T2DM have ∼30% less mitochondria in their muscles than lean control subjects, it appears to be widely accepted that mitochondrial “deficiency” is responsible for insulin resistance. The proposed mechanism for this effect is an impaired ability to oxidize fat, resulting in lipid accumulation in muscle. The purpose of this counterpoint article is to review the evidence against the mitochondrial deficiency concept. This evidence includes the findings that 1) development of insulin resistance in laboratory rodents fed high-fat diets occurs despite a concomitant increase in muscle mitochondria; 2) mitochondrial deficiency severe enough to impair fat oxidation in resting muscle causes an increase, not a decrease, in insulin action; and 3) most of the studies comparing fat oxidation in insulin-sensitive and insulin-resistant individuals have shown that fat oxidation is higher in T2DM patients and obese insulin-resistant individuals than in insulin-sensitive control subjects. In conclusion, it seems clear, based on this evidence, that the 30% reduction in muscle content of mitochondria in patients with T2DM is not responsible for insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Despite the numerous reports of mitochondrial dysfunction in type 2 diabetes, the hypothesis that a reduced mitochondrial capacity is the primary cause of insulin resistance has been substantially challenged over the years [4–6].”
From Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity (2021) · cites this paper as [5]
In the citing paper
“However, contradictory to this, some studies have shown that fat oxidation is increased in the muscle of T2D patients.200”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [200]
In the citing paper
“Decreased numbers of mitochondria have been observed in the muscle cells of T2D patients, which has created the notion that a decreased population of mitochondria induces insulin resistance.200”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [200]
In the citing paper
“Furthermore, decreasing the mitochondrial population or disrupting mitochondrial function increases basal and insulin-stimulated glucose uptake into rodent skeletal muscle.200”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [200]
In the citing paper
“Finally, T2DM patients, despite having a 30% lower mitochondrial content, have higher mitochondrial oxidation rates and do not have an intrinsic problem to increase their whole-body fat oxidation rate during exercise (Larsen et al, 2009; Holloszy, 2013).”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Holloszy, 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 1×
“(48) that fat oxidation inhibits glucose uptake and metabolism and is, therefore, referred to as the “Randle COUNTERPOINT”
BackgroundDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321 · cited 3×
“The mitochondria in diabetic muscle were also smaller than normal (1).”
BackgroundMethodMitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096 · cited 3×
“This claim is puzzling, both because their initial reports that T2DM patients have “mitochondrial dysfunction” were largely based on the finding of decreases in citrate synthase (1,3), and carnitine palmityl transferase (2), and because the studies by Pospisilik et al.”
BackgroundMethodHandschin, C., & Spiegelman, B. M. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0037 · Cited by 1,090 · cited 5×
“The investigators who performed these studies concluded that the increase in mitochondrial biogenesis was mediated directly by PPAR-b, because overexpression of PPAR-b in muscle did not result in an increase in peroxisome proliferator–activated receptor g coactivator-1a (PGC-1a) mRNA.”
BackgroundInfluentialRegulation of Muscle Fiber Type and Running Endurance by PPARδ
Wang, Y.-X., Zhang, C.-L., Yu, R. T., Cho, H. K., Nelson, M. C., Bayuga-Ocampo, C. R., Ham, J., Kang, H., & Evans, R. M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020294 · Cited by 1,089 · cited 1×
“Previous studies had shown that overexpression or activation of PPAR-b in muscle induces an increase in mitochondrial biogenesis (25,26).”
BackgroundMorino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853 · cited 1×
“As a result of the many studies showing that T2DM patients, insulin-resistant obese people, and insulin resistant offspring of diabetic parents generally have a ;30% reduction in muscle mitochondria, the hypothesis that insulin resistance is mediated by a deficiency of muscle mitochondria appears to have gained consid…”
BackgroundBonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.-A., Morio, B., Vidal, H., & Rieusset, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32601 · Cited by 819 · cited 1×
“A second is that it is mediated by oxidative stress (13).”
Background
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Metabolites as regulators of insulin sensitivity and metabolism
Yang, Q., Vijayakumar, A., & Kahn, B. B. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0044-8 · Cited by 663
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution
Niemann, B., Rohrbach, S., Miller, M. R., Newby, D. E., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.043 · Cited by 353
Flockhart, M., Nilsson, L. C., Tais, S., Ekblom, B., Apró, W., & Larsen, F. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.02.017 · Cited by 257
Lepretti, M., Martucciello, S., Burgos Aceves, M., Putti, R., & Lionetti, L. (2018) · Nutrients · doi:10.3390/nu10030350 · Cited by 232
“However, due to the results of several studies showing no mitochondrial function impairment in insulin resistant humans, the most accredited recent theory on mitochondrial involvement in the etiopathogenesis of insulin resistance focuses on reactive oxygen species (ROS) production [26,27].”
BackgroundInfluential‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue
Pérez, L. M., Pareja‐Galeano, H., Sanchis‐Gomar, F., Emanuele, E., Lucia, A., & Gálvez, B. G. (2016) · The Journal of Physiology · doi:10.1113/jp271691 · Cited by 215
“The Journal of Physiology C© 2016 The Physiological Society (Of note, ‘deficiency’ of mitochondria in muscle does not cause insulin resistance per se in this tissue; Holloszy, 2013).”
BackgroundRyan, B. J., Schleh, M. W., Ahn, C., Ludzki, A. C., Gillen, J. B., Varshney, P., Van Pelt, D. W., Pitchford, L. M., Chenevert, T. L., Gioscia-Ryan, R. A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa345 · Cited by 202
From OCR and ECAR to energy: Perspectives on the design and interpretation of bioenergetics studies
Schmidt, C. A., Fisher-Wellman, K. H., & Neufer, P. D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101140 · Cited by 198
The Impact of Oxidative Stress on Adipose Tissue Energy Balance
Masschelin, P. M., Cox, A. R., Chernis, N., & Hartig, S. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01638 · Cited by 199
“Although the development of insulin resistance does not require impaired mitochondrial function (Hancock et al., 2008; Holloszy, 2013), pathways promoting insulin resistance may impair mitochondrial function and further increase ROS production, resulting in a detrimental feedback loop.”
BackgroundAlterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus
Koliaki, C., & Roden, M. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050656 · Cited by 165
Kunz, H., Hart, C. R., Gries, K. J., Parvizi, M., LAURENTI, M. C., Man, C. D., Moore, N., Zhang, X., Ryan, Z., Polley, E. C., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00070.2021 · Cited by 189
Insulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 173
Mitochondrial response to nutrient availability and its role in metabolic disease
Gao, A. W., Cantó, C., & Houtkooper, R. H. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303782 · Cited by 148
“Finally, T2DM patients, despite having a 30% lower mitochondrial content, have higher mitochondrial oxidation rates and do not have an intrinsic problem to increase their whole-body fat oxidation rate during exercise (Larsen et al , 2009; Holloszy, 2013).”
Mitophagy Directs Muscle-Adipose Crosstalk to Alleviate Dietary Obesity
Fu, T., Xu, Z., Liu, L., Guo, Q., Wu, H., Liang, X., Zhou, D., Xiao, L., Liu, L., Liu, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.127 · Cited by 145
Nisr, R. B., Shah, D. S., Ganley, I. G., & Hundal, H. S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03148-8 · Cited by 142
Axelrod, C. L., Fealy, C. E., Mulya, A., & Kirwan, J. P. (2018) · Acta Physiologica · doi:10.1111/apha.13216 · Cited by 130
“However, the integrity, morphology, structure, and functionality of mitochondria in chronic disease states remains heavily disputed.(12,13) Recent advances in molecular biology have redefined mitochondria as a morphologically plastic network sensitive to the bioenergetic demands of the cell.”
The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes
Martin, S. D., & McGee, S. L. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.019 · Cited by 113
Contrasting metabolic effects of medium- versus long-chain fatty acids in skeletal muscle
Montgomery, M. K., Osborne, B., Brown, S. H. J., Small, L., Mitchell, T. W., Cooney, G. J., & Turner, N. A. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m040451 · Cited by 122
Henstridge, D. C., Whitham, M., & Febbraio, M. A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.08.003 · Cited by 120
Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion
Hong, S., Zhou, W., Fang, B., Lu, W., Loro, E., Damle, M., Ding, G., Jager, J., Zhang, S., Zhang, Y., et al. (2016) · Nature Medicine · doi:10.1038/nm.4245 · Cited by 120
Sczelecki, S., Besse-Patin, A., Abboud, A., Kleiner, S., Laznik-Bogoslavski, D., Wrann, C. D., Ruas, J. L., Haibe-Kains, B., & Estall, J. L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00578.2013 · Cited by 108
“Defects in mitochondrial function in muscle as a cause of insulin resistance are widely debated (14, 22).”
BackgroundHenagan, T. M., Cefalu, W. T., Ribnicky, D. M., Noland, R. C., Dunville, K., Campbell, W. W., Stewart, L. K., Forney, L. A., Gettys, T. W., Chang, J. S., et al. (2015) · Genes & Nutrition · doi:10.1007/s12263-014-0451-1 · Cited by 102
“HFD has been shown to have varying effects on mitochondrial biogenesis that may occur independently of differences in mitochondrial function and insulin sensitivity and may be dependent on the duration of feeding and type and level of dietary fat (Hancock et al. 2008; Holloszy 2013).”
p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?
Bengal, E., Aviram, S., & Hayek, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186480 · Cited by 114
Putti, R., Migliaccio, V., Sica, R., & Lionetti, L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00426 · Cited by 102
“…different reviews focused on mechanism(s) by which mitochondrial bioenergetics (Fisher-Wellman and Neufer, 2012; Lark et al., 2012; Muoio and Neufer, 2012; Holloszy, 2013) and morphology (Liesa and Shirihai, 2013; Montgomery and Turner, 2015) may be linked to the etiology of IR in skeletal muscle.”
BackgroundInfluentialHouzelle, A., Jörgensen, J. A., Schaart, G., Daemen, S., van Polanen, N., Fealy, C. E., Hesselink, M. K. C., Schrauwen, P., & Hoeks, J. (2021) · Diabetologia · doi:10.1007/s00125-020-05335-w · Cited by 83
Dubé, J. J., Coen, P. M., DiStefano, G., Chacon, A. C., Helbling, N. L., Desimone, M. E., Stafanovic-Racic, M., Hames, K. C., Despines, A. A., Toledo, F. G. S., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2014 · Cited by 83
“The causal role for mitochondrial function in insulin sensitivity is controversial (17, 22).”
BackgroundDaniele, G., Eldor, R., Merovci, A., Clarke, G. D., Xiong, J., Tripathy, D., Taranova, A. G., Abdul-Ghani, M. A., & DeFronzo, R. A. (2013) · Diabetes · doi:10.2337/db13-1130 · Cited by 87
Bonen, A., Jain, S. S., Snook, L. A., Han, X.-X., Yoshida, Y., Buddo, K. H., Lally, J., Pask, E. D., Paglialunga, S., Beaudoin, M., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3691-8 · Cited by 89
Cappellari, G. G., Zanetti, M., Semolic, A., Vinci, P., Ruozi, G., Falcione, A., Filigheddu, N., Guarnieri, G., Graziani, A., Giacca, M., et al. (2016) · Diabetes · doi:10.2337/db15-1019 · Cited by 90
“Our results therefore provide further evidence against a role for low mitochondrial function to primarily cause insulin resistance (41-45), conversely indicating UnAG as a novel modulator of muscle mitochondrial activity with negative impact on both ATP and ROS production in vivo.”
BackgroundLipid-Induced Mechanisms of Metabolic Syndrome
Denisenko, Y., Kytikovа, O. Y., Novgorodtseva, T. P., Antonyuk, M. V., Gvozdenko, T. A., & Анатольевна, К. Т. (2020) · Journal of Obesity · doi:10.1155/2020/5762395 · Cited by 87
Liu, Y., Qi, W., Richardson, A. G., Remmen, H. V., Ikeno, Y., & Salmon, A. B. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.029 · Cited by 79
“However, there is some discrepancy in the literature on whether obesity actually negatively affects mitochondria function or whether diabetes itself is associated with mitochondrial dysfunction [20].”
BackgroundSkeletal Muscle Triacylglycerol Hydrolysis Does Not Influence Metabolic Complications of Obesity
Sitnick, M. T., Basantani, M. K., Cai, L., Schoiswohl, G., Yazbeck, C. F., Distefano, G., Ritov, V., DeLany, J. P., Schreiber, R., Stolz, D. B., et al. (2013) · Diabetes · doi:10.2337/db13-0500 · Cited by 73
“Furthermore, accumulating evidence suggests that muscle oxidative capacity cannot entirely explain differences in IMTGs or insulin responsiveness (12).”
BackgroundMitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67
“arguments are summarized in [201] and [202], respectively.”
Juraschek, S. P., Selvin, E., Miller, E. R., Brancati, F. L., & Young, J. H. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.09.005 · Cited by 64
“There is currently much debate regarding the role of oxidative capacity in the pathogenesis of diabetes [20,21].”
BackgroundBesse‐Patin, A., & Estall, J. L. (2014) · International Journal of Cell Biology · doi:10.1155/2014/519153 · Cited by 71
“Conversely, some argue that insulin resistance, resulting from nutrient overload and mitochondrial exhaustion, is the initiating event leading to mitochondrial dysfunction and increased ROS in metabolic disease [64].”
BackgroundDantas, W. S., Roschel, H., Murai, I. H., Gil, S., Davuluri, G., Axelrod, C. L., Ghosh, S., Newman, S. S., Zhang, H., Shinjo, S. K., et al. (2020) · Diabetes · doi:10.2337/db19-1180 · Cited by 54
3,5-diiodothyronine: a novel thyroid hormone metabolite and potent modulator of energy metabolism
Senese, R., de Lange, P., Petito, G., Moreno, M., Goglia, F., & Lanni, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00427 · Cited by 52
Are Alterations in Skeletal Muscle Mitochondria a Cause or Consequence of Insulin Resistance?
Genders, A. J., Holloway, G. P., & Bishop, D. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186948 · Cited by 51
“As noted by Lewis et al. [87] and Holloszy [83], the many ways mitochondrial respiratory function has been measured in the literature has likely contributed to some of the conflicting findings.”
MethodInfluentialNisr, R. B., & Affourtit, C. (2014) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.10.012 · Cited by 51
“Insufficient mitochondrial capacity to burn excess fatty acids has been held responsible for obesity-blunted insulin sensitivity [5], but this notion is highly controversial [6].”
Fiorenza, M., Onslev, J., Henríquez‐Olguín, C., Persson, K. W., Hesselager, S. A., Jensen, T. E., Wojtaszewski, J. F. P., Hostrup, M., & Bangsbo, J. (2024) · Science Advances · doi:10.1126/sciadv.adq4461 · Cited by 64
Reduced efficiency of sarcolipin-dependent respiration in myocytes from humans with severe obesity
Paran, C. W., Verkerke, A. R. P., Heden, T. D., Park, S., Zou, K., Lawson, H. A., Song, H., TURK, J. W., Houmard, J. A., & Funai, K. (2015) · Obesity · doi:10.1002/oby.21123 · Cited by 52
“yield lower basal resting respiratory rates as ATP synthesis is regulated by ATP demand, not capacity (28,29).”
BackgroundMitochondrial Activity and Skeletal Muscle Insulin Resistance in Kidney Disease
Carré, J. E., & Affourtit, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112751 · Cited by 48
“The causality of mitochondrial involvement in nutrient-induced insulin resistance has been debated for some time [72,73], and the dispute is ongoing [74].”
BackgroundJana, B. A., Chintamaneni, P. K., Krishnamurthy, P. T., Wadhwani, A., & Mohankumar, S. K. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4551-7 · Cited by 48
Öhman, T., Teppo, J., Datta, N., Mäkinen, S., Varjosalo, M. T., & Koistinen, H. A. (2021) · iScience · doi:10.1016/j.isci.2021.102712 · Cited by 39
“While there is a consensus on skeletal muscle mitochondrial dysfunction in insulin resistance and T2D, it remains much debated if the decrease in mitochondrial oxidative metabolism is causal to insulin resistance and diabetic metabolism (Goodpaster, 2013; Holloszy, 2013; Patti and Corvera, 2010; Pinti et al., 2019).”
BackgroundHandy, R. M., & Holloway, G. P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1151389 · Cited by 38
“Additionally, the induction of insulin resistance can occur in the absence of reductions in mitochondrial content (Bruce et al., 2005; Holloszy, 2013) or reductions in isolated mitochondrial fatty acid oxidation (Holloway et al., 2007; 2009; Mogensen et al., 2007).”
BackgroundGorgey, A. S., Khalil, R. E., Gill, R. S., O’Brien, L. C., Lavis, T. D., Castillo, T. A., Cifu, D. X., Savas, J. F., Khan, R., Cardozo, C. P., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014125 · Cited by 38
Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm
Bar‐Tana, J. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09545-w · Cited by 44
Pino, M. F., Stephens, N. A., Eroshkin, A. M., Yi, F., Hodges, A. P., Cornnell, H. H., Pratley, R. E., Smith, S. R., Wang, M., Han, X., et al. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00014.2019 · Cited by 35
Hong, J. H., Kim, B.-W., Choo, H. J., Park, J.-J., Yi, J.-S., Yu, D., Lee, H., Yoon, G.-S., Lee, J., & Ko, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.560078 · Cited by 40
Thrush, A. B., Dent, R., McPherson, R., & Harper, M. (2013) · FEBS Journal · doi:10.1111/febs.12399 · Cited by 41
Insulin action and resistance are dependent on a GSK3β-FBXW7-ERRα transcriptional axis
Xia, H., Scholtes, C., Dufour, C. R., Ouellet, C., Ghahremani, M., & Giguère, V. (2022) · Nature Communications · doi:10.1038/s41467-022-29722-6 · Cited by 34
Zamora, M., Pardo, R., & Villena, J. A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.032 · Cited by 34
Sharma, N., Sajuthi, S. P., Chou, J. W., Calles-Escandón, J., Demons, J. L., Rogers, S. D., Ma, L., Palmer, N. D., McWilliams, D. R., Beal, J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3336 · Cited by 38
Webster, C. C., van Boom, K. M., Armino, N., Larmuth, K., Noakes, T. D., Smith, J. A. H., & Kohn, T. A. (2020) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2019-0359 · Cited by 33
“Impaired fat oxidation was once considered a common feature of pathological insulin resistance (Holloszy, 2013; Hulver et al., 2003; Kelley et al., 1999; Kim et al., 2000).”
BackgroundIslam, H., & Gillen, J. B. (2023) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2023.01.002 · Cited by 40
Mitochondrial function in metabolic health: A genetic and environmental tug of war
Stephenson, E. J., & Hawley, J. A. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.004 · Cited by 32
Siripoksup, P., Cao, G., Cluntun, A. A., Maschek, J. A., Pearce, Q., Brothwell, M. J., Jeong, M.-Y., Eshima, H., Ferrara, P. J., Opurum, P. C., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci167371 · Cited by 30
Mitochondrial quality control in insulin resistance and diabetes
Wanagat, J., & Hevener, A. L. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.05.007 · Cited by 24
“As a central player in metabolism and the “powerhouse” of the cell, the mitochondrion has long been implicated in the regulation of metabolic flux and insulin action although, to date, this remains an active and contentious area of research.[1,2] A number of recent reviews have examined the role of mitochondrial quali…”
BackgroundNieblas, B., Pérez-Treviño, P., & García, N. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.959844 · Cited by 28
“Similarly, in HFD rat models, an increase in mitochondrial content and lipid oxidation were observed, suggesting that decreased mitochondrial activity is not a direct link to IR (Holloszy, 2013).”
BackgroundShen, J., Wang, X., Wang, M., & Zhang, H. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1337442 · Cited by 30
“…indicated that insulin resistance may not be a consequence of decreased mitochondrial numbers, although the mitochondrial function is vital for the action of insulin, insulin resistance does not arise when the mitochondrial electron transport chain is disrupted (Han et al., 2011; Holloszy, 2013).”
BackgroundFalcão‐Tebas, F., Kuang, J., Arceri, C., Kerris, J. P., Andrikopoulos, S., Marin, E. C. S., & McConell, G. K. (2018) · The Journal of Physiology · doi:10.1113/jp276386 · Cited by 26
“Some studies have indicated that skeletal muscle mitochondrial function can influence insulin sensitivity (Szendroedi et al. 2012; Holloszy, 2013; Martin & McGee, 2014).”
BackgroundLund, M. T., Larsen, S., Hansen, M. V., Courraud, J., Floyd, A. K., Støckel, M., Helge, J. W., & Dela, F. (2018) · Acta Physiologica · doi:10.1111/apha.13032 · Cited by 24
Effects of estrogens and androgens on mitochondria under normal and pathological conditions
Mohajeri, M., Martín-Jiménez, C., Barreto, G. E., & Sahebkar, A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.03.001 · Cited by 23
“It is hypothesized that the skeletal muscle mitochondrial function reduces in metabolic disorders, resulting in declined fatty acid oxidation which contributes to insulin resistance (Goodpaster, 2013; Holloszy, 2013).”
Flensted-Jensen, M., Gram, M., Dela, F., Helge, J. W., & Larsen, S. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.020 · Cited by 27
Lipid Behavior in Metabolic Syndrome Pathophysiology
Marzoog, B. A. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210915101321 · Cited by 27
Parry, H. A., & Glancy, B. C. (2021) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100487 · Cited by 25
Dubé, J. J., Collyer, M. L., Trant, S., Toledo, F. G. S., Goodpaster, B. H., Kershaw, E. E., & DeLany, J. P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz272 · Cited by 25
The manifold role of the mitochondria in skeletal muscle insulin resistance
Cade, W. T. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000480 · Cited by 21
Nisr, R. B., & Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.04.286 · Cited by 23
“Mitochondrial capacity per se may indeed be sufficient to cope with the lipid load in the obese state [11], but without energy demand this capacity will be inconsequential.”
BackgroundInfluentialImpact of prolonged overfeeding on skeletal muscle mitochondria in healthy individuals
Toledo, F. G. S., Johannsen, D. L., Covington, J. D., Bajpeyi, S., Goodpaster, B. H., Conley, K. E., & Ravussin, É. (2017) · Diabetologia · doi:10.1007/s00125-017-4496-8 · Cited by 23
“The physiological implications remain a subject of ongoing debate [3, 4] but it has been suggested that impaired mitochondrial capacity leads to increased deposition of ectopic lipids in skeletal muscle tissue and liver and the development of insulin resistance [1, 5–7].”
BackgroundWang, D., Jiang, D.-M., Yu, R.-R., Zhang, L., Liu, Y.-Z., Chen, J.-X., Chen, H., & Liu, Y. (2022) · Journal of Diabetes Research · doi:10.1155/2022/3780156 · Cited by 24
Blackwood, S. J., Horwath, O., Moberg, M., Pontén, M., Apró, W., Ekblom, M., Larsen, F. J., & Katz, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac221 · Cited by 18
Passive heat stress induces mitochondrial adaptations in skeletal muscle
Marchant, E. D., Nelson, W. B., Hyldahl, R. D., Gifford, J. R., & Hancock, C. R. (2023) · International Journal of Hyperthermia · doi:10.1080/02656736.2023.2205066 · Cited by 20
“However, this notion has been widely debated and likely involves several complex mechanisms [40,41,44,45].”
BackgroundSong, Y., & Lan, H. (2024) · Journal of Sports Science and Medicine · doi:10.52082/jssm.2024.690 · Cited by 26
“Long-term metabolic adaptations in skeletal muscles could result from enhanced oxidative capacity and mitochondrial respiratory protein abundance (Ryan et al., 2020; Kelley et al., 1999; Goodpaster et al., 2003; 2013; Holloszy, 2009; 2013; Muoio and Neufer, 2012).”
BackgroundNisr, R. B., Shah, D. S., & Hundal, H. S. (2020) · Cellular Physiology and Biochemistry · doi:10.33594/000000282 · Cited by 20
Lai, N., Fealy, C. E., Kummitha, C., Cabras, S., Kirwan, J. P., & Hoppel, C. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00677 · Cited by 15
“In the current study, the finding that mitochondrial function was similar in both diabetic and nondiabetic muscle, despite a reduction in mitochondrial content, adds to the growing body of literature (Boushel et al., 2007; Holloway, 2009; Hoeks et al., 2010; Holloszy, 2013; Muoio, 2014) that contradicts the notion of…”
BackgroundResultRen, J., Sherry, A. D., & Malloy, C. R. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27686 · Cited by 15
Pelt, D. W. V., Newsom, S. A., Schenk, S., & Horowitz, J. F. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.70 · Cited by 16
Silvestri, E., Cioffi, F., Matteis, R. D., Senese, R., de Lange, P., Coppola, M., Salzano, A. M., Scaloni, A., Ceccarelli, M., Goglia, F., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00194 · Cited by 16
“In addition, this work, in line with very recent ones (Zhang and Ye, 2012; Holloszy, 2013; Meng et al., 2013), further supports how the oxidative-to-glycolytic metabolic shift in skeletal muscle is potentially beneficial in hyperglycemic/prediabetic states (de Lange et al., 2011).”
BackgroundResultCommentary: Mitochondrial DNA damage and loss in diabetes
Gilkerson, R. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2833 · Cited by 16
“[1], subsequent murine studies suggest that loss of mitochondrial function is not causative for insulin resistance [23,24].”
Wang, Y., Fouret, G., Bonafos, B., Błachnio-Zabielska, A. U., Leroy, T., Crouzier, D., Baréa, B., Gaillet, S., Moro, C., Lecomte, J., et al. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.10.021 · Cited by 14
Frangos, S. M., Bishop, D. J., & Holloway, G. P. (2021) · Biochemical Journal · doi:10.1042/bcj20210145 · Cited by 15
Impact of moderate exercise on fatty acid oxidation in pancreatic β-cells and skeletal muscle
Langlois, A., Forterre, A. V., Pinget, M., & Bouzakri, K. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01551-2 · Cited by 18
“For years, whether the FA oxidation alteration (mitochondrial dysfunction) is the trigger or not of insulin signaling impairment inducing insulin resistance onset was the subject of extensive discussions [50, 52, 54, 55].”
BackgroundMacia, M., Pecchi, É., Vilmen, C., Desrois, M., Lan, C., Portha, B., Bernard, M., Bendahan, D., & Giannesini, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129579 · Cited by 15
Jones, S. H., Tillin, T., Williams, S., Eastwood, S. V., Hughes, A. D., & Chaturvedi, N. (2019) · Diabetologia · doi:10.1007/s00125-019-05055-w · Cited by 17
Brøns, C., Lilleøre, S. K., Astrup, A. V., & Vaag, A. A. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-1018-7 · Cited by 10
“1 3 contrast, more recent studies have challenged this hypothesis [15, 29].”
BackgroundMäkinen, S., Sree, S., Ala‐Nisula, T., Kultalahti, H., Koivunen, P., & Koistinen, H. A. (2024) · Diabetologia · doi:10.1007/s00125-024-06185-6 · Cited by 14
Jevtovic, F., Zheng, D., Lopez, C. A., Kern, K., Tanner, C. J., Jones, T. E., Pories, W. J., Dohm, G. L., Houmard, J. A., May, L. E., et al. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00159.2023 · Cited by 9
Calabria, E., Muollo, V., Cavedon, V., Capovin, T., Saccenti, L., Passarotti, F., Ghiotto, L., Milanese, C., Gelati, M., Rudi, D., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11010121 · Cited by 10
“Several studies focused on defects of mitochondrial function in T2D, but despite abundant data, it is still unclear whether perturbations of mitochondrial functions are a cause or a consequence of insulin resistance [61,62].”
BackgroundMacia, M., Pecchi, É., Desrois, M., Lan, C., Vilmen, C., Portha, B., Bernard, M., Bendahan, D., & Giannesini, B. (2018) · Biochimie · doi:10.1016/j.biochi.2018.02.014 · Cited by 7
“Besides, it must be underlined that glucose metabolism enhancement occurred independently of any mitochondrial impairment, which is consistent with the assumption that DT2M-induced mitochondrial dysfunction cannot be considered as the direct cause of the impaired glucose metabolism [32, 33].”
BackgroundKang, Y. S., Seong, D., Kim, J.-C., & Kim, S. H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17155461 · Cited by 8
Omar, A. K., Puma, L. C. L., Whitcomb, L. A., Risk, B. D., Witt, A. C., Bruemmer, J. E., Winger, Q. A., Bouma, G. J., & Chicco, A. J. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00059.2023 · Cited by 6
Goodpaster, B. H., & Coen, P. M. (2014) · Diabetes · doi:10.2337/db14-0277 · Cited by 7
Diabetes, myometrium, and mitochondria in pregnant women at term
Gam, C. M. B. F., Mortensen, O. H., Larsen, L. H., Poulsen, S. S., Qvortrup, K., Mathiesen, E. R., Damm, P., & Quistorff, B. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1171-6 · Cited by 7
Exercise does not improve insulin resistance and mitochondrial characteristics together
Genders, A. J., Kuang, J., Marin, E. C., Saner, N. J., Botella, J., Jacques, M., McConell, G. K., Andrade-Souza, V. A., Chagolla, J., & Bishop, D. J. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0242 · Cited by 4
de Almeida, M. E., Ørtenblad, N., Platz, A., Petersen, M. H., Højlund, K., & Nielsen, J. (2026) · Diabetologia · doi:10.1007/s00125-026-06694-6 · Cited by 4
“…with type 2 diabetes, the mitochondrial network is frequently fragmented and structurally altered [5–9]; this has been linked to reduced oxidative metabolism [10, 11] and impaired oxidative phosphorylation capacity in most studies [9, 12–17], although some have reported preserved function [18–20].”
Musi, N., & Bartke, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_12 · Cited by 6
Osborne, B., Brandon, A. E., Smith, G. C., & Turner, N. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811752-1.00016-x · Cited by 5
Metadata
- Authors
- Holloszy, J. O.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Holloszy, John O.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2013-03-14
- Volume
- 62
- Issue
- 4
- Pages
- 1036-1040
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3609559
- OpenAlex
- W2169835146
- Cited by
- 111
- References
- 49
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 11 · 2020: 13 · 2019: 9 · 2018: 14 · 2017: 4 · 2016: 11 · 2015: 7 · 2014: 8 · 2013: 11
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Longer Life Foundation
- National Institute for Health and Care Research
- National Institutes of Health
- National Institute on Aging (R01AG000425, R37AG000425, Z01AG000425, R56AG000425)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- muscle mitochondria, insulin resistance, type 2 diabetes, fat oxidation, high-fat diet, obesity, insulin sensitivity, skeletal muscle
- MeSH terms
- Adipose Tissue, Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Humans, Insulin Resistance, Mitochondria, Muscle, Obesity, Oxidation-Reduction, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.